Filing Flows

Filing Flows › Companies › Accendra Health › Cash flow

Accendra Health cash flow, quarter by quarter

Latest: Q3 2026 · from the cash-flow statements filed with the SEC

Free cash flow−$56.6M in Q3 2026 · −$199M over twelve months

Operating cash flow−$17.4M
Capital spending−$39.2M
Free cash flow−$56.6M

Analysis

In Q3 2026, Accendra Health generated −$17.4M of operating cash flow and spent $39.2M on capital projects, leaving free cash flow of −$56.6M. That is $158M more than in Q3 2025 (−$215M).

Over the twelve months to Sep 30, 2026, operating cash flow was −$25.3M; the largest uses were net borrowing (+) / repaid (−) ($236M), capital spending ($174M), other financing ($72.1M); besides operations, cash came from other investing ($338M), asset & business sales ($150M); the cash balance fell by $19.6M.

Operating cash flow was −$17.4M against net income of −$19.7M. The largest differences: depreciation & amortization +$38.9M, other operating capital −$24.3M, payables +$22.0M.

Free cash flow

Accendra Health: free cash flow by quarterAccendra Health: free cash flow by quarter$48.7MQ4 2024−$80.9MQ1 2025−$20.0MQ2 2025−$215MQ3 2025$22.8MQ4 2025−$91.7MQ1 2026−$73.6MQ2 2026−$56.6MQ3 2026
Operating cash flow less capital spending.
Accendra Health: operating cash flow against capital spendingAccendra Health: operating cash flow against capital spendingOperating cash flowCapital spending$71.0M$22.3MQ4 2024−$35.1M$45.8MQ1 2025$37.6M$57.6MQ2 2025−$173M$42.1MQ3 2025$68.2M$45.4MQ4 2025−$50.1M$41.6MQ1 2026−$26.0M$47.6MQ2 2026−$17.4M$39.2MQ3 2026
Latest (Q3 2026): Operating cash flow −$17.4M, Capital spending $39.2M.

Capital allocation, year by year

Accendra Health: where the cash came from (up) and went (down), by fiscal yearAccendra Health: where the cash came from (up) and went (down), by fiscal yearOperating cash flowNet borrowingAsset salesCapital spendingAcquisitionsBuybacksDividendsFY2021: Operating cash flow $124MFY2021: Net borrowing −$82.6MFY2021: Capital spending −$49.7MFY2021: Dividends −$731K$124MFY2021FY2022: Operating cash flow $325MFY2022: Net borrowing $1.7BFY2022: Asset sales $48.4MFY2022: Capital spending −$167MFY2022: Acquisitions −$1.7B$2.1BFY2022FY2023: Operating cash flow $741MFY2023: Net borrowing −$323MFY2023: Asset sales $71.6MFY2023: Capital spending −$208M$812MFY2023FY2024: Operating cash flow $161MFY2024: Net borrowing −$247MFY2024: Asset sales $69.9MFY2024: Capital spending −$170M$231MFY2024FY2025: Operating cash flow −$102MFY2025: Net borrowing $204MFY2025: Asset sales $420MFY2025: Capital spending −$191MFY2025: Acquisitions −$18.1MFY2025: Buybacks −$10.2M$624MFY2025
Over these 5 years operating cash flow totalled $1.2B; the largest uses were acquisitions ($1.7B) and capital spending ($785M). Cash-flow statements as filed.

Cash runway and the debt wall

Cash & investments$26.6M
Debt$1.8B
Net debt$1.7B
Due within a year$250M
Cash runway2 months

Accendra Health is burning cash: its operations consume cash, a free cash flow of −$199M a year at the current rate against $26.6M of cash and investments: a runway of about 2 months; $250M of debt also comes due within a year, which would need refinancing or new money before any new financing.

Accendra Health: debt maturities by year (FY2025)Accendra Health: debt maturities by year (FY2025)$250MYear 1$280MYear 2$990MYear 4$552MYear 5
Principal due in each year as disclosed in the annual report, against $26.6M of cash and investments now.

Where the cash came from and went

Accendra Health: sources (+) and uses (−) of cash, Q3 2026Accendra Health: sources (+) and uses (−) of cash, Q3 2026Capital spending−$39.2MNet borrowing (+) / repaid (−)$35.0MOther investing$31.6MCash drawn (+) / kept (−)−$19.0MOperating cash flow−$17.4MAsset & business sales$13.3MOther financing−$4.4MExchange rates$1K
Accendra Health: sources (+) and uses (−) of cash, TTM to Q3 2026Accendra Health: sources (+) and uses (−) of cash, TTM to Q3 2026Other investing$338MNet borrowing (+) / repaid (−)−$236MCapital spending−$174MAsset & business sales$150MOther financing−$72.1MOperating cash flow−$25.3MCash drawn (+) / kept (−)$19.6MExchange rates$89K

From profit to cash

Accendra Health: net income to operating cash flow, Q3 2026Accendra Health: net income to operating cash flow, Q3 2026Net income−$19.7MDepreciation & amortization$38.9MStock-based pay$2.1MDeferred taxes−$5.3MGains on disposals−$5.9MOther non-cash−$3.7MInventory−$11.1MPayables$22.0MOther operating capital−$24.3MOperating cash flow−$17.4M
Non-cash charges are added back; money tied up in receivables or inventory is subtracted.

Every quarter

QuarterOperating cash flowCapital spendingAcquisitionsBuybacksNet borrowing (+) / repaid (−)Cash drawn (+) / kept (−)Free cash flow
Q3 2026−$17.4M−$39.2M——$35.0M−$19.0M−$56.6M
Q2 2026−$26.0M−$47.6M——−$255M$329M−$73.6M
Q1 2026−$50.1M−$41.6M——$51.5M−$54.9M−$91.7M
Q4 2025$68.2M−$45.4M—−$3.5M−$67.2M−$236M$22.8M
Q3 2025−$173M−$42.1M——$136M$30.9M−$215M
Q2 2025$37.6M−$57.6M—−$5.2M$37.5M−$17.7M−$20.0M
Q1 2025−$35.1M−$45.8M−$55.7M−$1.5M$97.5M−$10.1M−$80.9M
Q4 2024$71.0M−$22.3M——−$32.8M$25.7M$48.7M

Accendra Health: income statement and cash flow

Accendra Health, Q3 2026: revenue $602M (-14% year over year), operating margin 0.2%. The chart follows the revenue to costs, profit and cash.

Accendra Health: every quarter, Q/Q and Y/Y → Open in the app

Read automatically from the company’s XBRL cash-flow statements; quarterly figures for the fourth quarter are the year less the first three. Errors are possible. Not investment advice.